Nurix Therapeutics (NRIX) News Today $9.34 -0.07 (-0.74%) Closing price 08/29/2025 04:00 PM EasternExtended Trading$9.34 0.00 (0.00%) As of 08/29/2025 05:38 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock NRIX Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Nurix Therapeutics, Inc. $NRIX Shares Acquired by Russell Investments Group Ltd.August 30 at 3:41 AM | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Stock Rating Upgraded by Baird R WAugust 29 at 6:06 AM | marketbeat.comNurix Therapeutics to Participate in Upcoming Investor ConferencesAugust 28 at 4:01 PM | globenewswire.comNurix Therapeutics, Inc. $NRIX Shares Sold by Affinity Asset Advisors LLCAugust 28 at 9:02 AM | marketbeat.comVanguard Group Inc. Acquires 69,856 Shares of Nurix Therapeutics, Inc. $NRIXAugust 28 at 3:11 AM | marketbeat.comBaird R W Upgrades Nurix Therapeutics (NASDAQ:NRIX) to "Strong-Buy"August 28 at 2:19 AM | americanbankingnews.comNurix Therapeutics, Inc. $NRIX Shares Sold by Wellington Management Group LLPAugust 27 at 4:11 AM | marketbeat.comNurix Therapeutics, Inc. $NRIX Shares Bought by T. Rowe Price Investment Management Inc.August 26, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Given Average Rating of "Moderate Buy" by BrokeragesAugust 26, 2025 | marketbeat.comNurix Therapeutics, Inc. $NRIX Shares Sold by Candriam S.C.A.August 24, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Given Consensus Recommendation of "Moderate Buy" by AnalystsAugust 24, 2025 | americanbankingnews.comNurix Therapeutics (NASDAQ:NRIX) Trading Down 4.4% - Time to Sell?August 20, 2025 | marketbeat.comDeutsche Bank AG Has $4.52 Million Position in Nurix Therapeutics, Inc. $NRIXAugust 19, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Trading Up 7.7% - Should You Buy?August 15, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Shares Sold by Victory Capital Management Inc.August 3, 2025 | marketbeat.comHoute Hans Van Sells 5,402 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) StockAugust 2, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Houte Hans Van Sells 5,402 SharesAugust 2, 2025 | insidertrades.comOppenheimer Reiterates "Outperform" Rating for Nurix Therapeutics (NASDAQ:NRIX)August 1, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) CFO Sells $51,691.04 in StockJuly 31, 2025 | marketbeat.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Insider Gwenn Hansen Sells 4,308 SharesJuly 31, 2025 | marketbeat.com6NRIX : 6 Analysts Assess Nurix Therapeutics: What You Need To KnowJuly 31, 2025 | benzinga.comHoute Hans Van Sells 4,304 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX) StockJuly 31, 2025 | insidertrades.comNurix Therapeutics (NASDAQ:NRIX) Shares Up 4.9% - Here's What HappenedJuly 29, 2025 | marketbeat.comY Intercept Hong Kong Ltd Invests $374,000 in Nurix Therapeutics, Inc. (NASDAQ:NRIX)July 29, 2025 | marketbeat.comARK Investment Management LLC Has $18.90 Million Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)July 27, 2025 | marketbeat.comNikko Asset Management Americas Inc. Decreases Holdings in Nurix Therapeutics, Inc. (NASDAQ:NRIX)July 27, 2025 | marketbeat.comNew York State Common Retirement Fund Has $626,000 Stock Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)July 26, 2025 | marketbeat.comMassachusetts Financial Services Co. MA Sells 24,398 Shares of Nurix Therapeutics, Inc. (NASDAQ:NRIX)July 22, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Shares Down 5.4% - Here's What HappenedJuly 19, 2025 | marketbeat.comHussman Strategic Advisors Inc. Takes Position in Nurix Therapeutics, Inc. (NASDAQ:NRIX)July 19, 2025 | marketbeat.comQ3 EPS Forecast for Nurix Therapeutics Raised by AnalystJuly 16, 2025 | marketbeat.comNurix Therapeutics price target lowered to $34 from $36 at H.C. WainwrightJuly 15, 2025 | finance.yahoo.comNurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $34.00 at HC WainwrightJuly 14, 2025 | marketbeat.comLeerink Partnrs Analysts Lift Earnings Estimates for NRIXJuly 14, 2025 | marketbeat.comNurix Therapeutics Could Disrupt BTK Therapy And Reward InvestorsJuly 13, 2025 | seekingalpha.comNurix Therapeutics beats quarterly expectations on strong collaboration ...July 11, 2025 | investing.comUBS Group Cuts Nurix Therapeutics (NASDAQ:NRIX) Price Target to $26.00July 10, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Shares Gap Up After Earnings BeatJuly 10, 2025 | marketbeat.comNurix Therapeutics (NASDAQ:NRIX) Price Target Lowered to $30.00 at OppenheimerJuly 10, 2025 | marketbeat.comNurix Therapeutics' (NRIX) Overweight Rating Reaffirmed at StephensJuly 10, 2025 | marketbeat.comNurix Therapeutics, Inc.: Nurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate UpdateJuly 10, 2025 | finanznachrichten.deNurix Therapeutics Reports Increased Revenue Amid Net LossJuly 9, 2025 | tipranks.comNurix Therapeutics Climbs After 2Q Revenue TriplesJuly 9, 2025 | marketwatch.comNurix Therapeutics beats quarterly expectations on strong collaboration revenueJuly 9, 2025 | in.investing.comNurix Therapeutics Reports Second Quarter 2025 Financial Results and Provides a Corporate UpdateJuly 9, 2025 | globenewswire.comNurix Therapeutics (NASDAQ:NRIX) Trading 7.8% Higher - Still a Buy?July 9, 2025 | marketbeat.comEuropean Medicines Agency Grants Bexobrutideg (NX-5948) Orphan Drug Designation for the Treatment of Lymphoplasmacytic Lymphoma, also Known as Waldenström MacroglobulinemiaJuly 7, 2025 | globenewswire.comWall Street Analysts Predict a 143.41% Upside in Nurix Therapeutics (NRIX): Here's What You Should Know - NasdaqJuly 5, 2025 | nasdaq.comNurix Therapeutics, Inc. (NRIX) Expected to Beat Earnings Estimates: What to Know Ahead of Q2 Release - NasdaqJuly 5, 2025 | nasdaq.comNurix Therapeutics, Inc. (NASDAQ:NRIX) Receives Average Recommendation of "Moderate Buy" from AnalystsJuly 5, 2025 | marketbeat.com Get Nurix Therapeutics News Delivered to You Automatically Sign up to receive the latest news and ratings for NRIX and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. NRIX Media Mentions By Week NRIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. NRIX News Sentiment▼1.281.05▲Average Medical News Sentiment NRIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. NRIX Articles This Week▼136▲NRIX Articles Average Week Get the Latest News and Ratings for NRIX and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Nurix Therapeutics and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies AMRX News XENE News ARWR News VKTX News CRNX News RARE News MOR News NAMS News HCM News BHC News Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:NRIX) was last updated on 8/30/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThink you missed gold’s boom? Think againIf you've been watching gold's historic run and wondering if it's too late… I've got good news. Because the...Investors Alley | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredMy NEXT $1 Trillion PredictionJames Altucher is making his next trillion-dollar prediction — and this time, it’s not Apple. He believes Elon...Paradigm Press | Sponsored“HELIOS”: My No. 1 Investment of the 2020sA mysterious new energy technology — backed by Nvidia, Google, and even legendary investors like Stanley Druck...Stansberry Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nurix Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nurix Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
